主页文献库搜索
Phase II trial of temsirolimus in patients with metastatic breast cancer.

Fleming(Gini F),Ma(Cynthia X),Huo(Dezheng)... Breast Cancer Res Treat 2013-06-14

...PIK3CA mutations; no association was found between prolonged stable disease and PIK3CA mutation or any immunohistochemic...

Initiating breast cancer by PIK3CA mutation.

Miller(Todd W) Breast Cancer Res 2013-02-07

...PIK3CA in luminal mammary epithelial cells induces tumorigenesis, implying that PIK3CA mutation is an early event in bre...

Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q2...

Brown(Jennifer R),Hanna(Megan),Tesar(Betha... Clin Cancer Res 2013-04-03

...PIK3CA amplification.,Our findings implicate amplifications of 3q26 focused on PIK3CA and 8q24 focused on MYC in CLL.

A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal ...

Collisson(Eric A),Trejo(Christy L),Silva(J... Cancer Discov 2013-03-20

...PIK3CA(H1047R), in the mouse pancreas leads to pancreatic intraepithelial neoplasia (PanIN) lesions. Moreover, concomita...

Prognostic and predictive biomarkers for epidermal growth factor receptor-tar...

Custodio(Ana),Feliu(Jaime) Crit Rev Oncol Hematol 2013-05-23

...PIK3CA mutations or loss of PTEN expression could also be useful for selecting patients with reduced chance to benefit f...

Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a patte...

Italiano(Antoine),Chen(Chun-Liang),Thomas(... Cancer 2013-03-06

...PIK3CA/AKT/mTOR) pathways frequently are altered in sarcoma with complex genomics, such as leiomyosarcoma (LMS) or undif...

The favorable impact of PIK3CA mutations on survival: an analysis of 2587 pat...

Dumont(Amaury G),Dumont(Sarah N),Trent(Jon... Chin J Cancer 2013-06-28

...PIK3CA mutations may be associated with either a favorable or a poor clinical outcome, compared with the wild-type PIK3C...

Comprehensive mutation analysis in colorectal flat adenomas.

Voorham(Quirinus J M),Carvalho(Beatriz),Sp... PLoS One 2013-01-10

...PIK3CA and NRAS, as well as selected mutations in CTNNB1 (β-catenin), EGFR, FBXW7 (CDC4), PTEN, STK11, MAP2K4, SMAD4, PI...

AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynam...

Yap(Timothy A),Walton(Mike I),Grimshaw(Kyl... Clin Cancer Res 2013-04-03

...PIK3CA-mutant BT474 breast, PTEN-deficient PC3 human prostate cancer, and PTEN-deficient MES-SA uterine tumor xenografts...

Oncogenic mutations in extramammary Paget's disease and their clinical releva...

Kang(Zhihua),Xu(Feng),Zhang(Qiao-an),Wu(Zh... Int J Cancer 2013-02-20

...PIK3CA, AKT1, CTNNB1 and APC genes as well as methylation and expression of CDH1 in 144 EMPD cases and 42 matched normal...

上一页 212 213 214 215 216 217 218 219 220 下一页 216 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com